Loading…
Discovery of potent antimicrobial peptide analogs of Ixosin-B
Antimicrobial peptides (AMPs) are recognized as a potential alternative class of antimicrobial agents because of their selectivity for prokaryotic cells and promise of minimizing the development of bacterial resistance. We developed a lead 11-mer peptide, KRLRRVWRRWR-amide (Fig. 1), which exhibited...
Saved in:
Published in: | Bioorganic & medicinal chemistry letters 2012-06, Vol.22 (12), p.4185-4188 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | Antimicrobial peptides (AMPs) are recognized as a potential alternative class of antimicrobial agents because of their selectivity for prokaryotic cells and promise of minimizing the development of bacterial resistance. We developed a lead 11-mer peptide, KRLRRVWRRWR-amide (Fig. 1), which exhibited potent antimicrobial activity and no hemolytic activity.
Antimicrobial peptides (AMPs) represent the first defense line against infection when organisms are infected by pathogens. These peptides are generally good targets for the development of antimicrobial agents. Peptide amide analogs of Ixosin-B, an antimicrobial peptide with amino acid sequence of QLKVDLWGTRSGIQPEQHSSGKSDVRRWRSRY, were designed, synthesized and examined for antimicrobial activities against Escherichia coli, Staphylococcus aureus, and Pseudomonas aeruginosa. Within the peptides synthesized, we discovered an 11-mer peptide, KRLRRVWRRWR-amide, which exhibited potent antimicrobial activity while very little hemolytic activity in human erythrocytes was observed even at high dose level (100μM). With further modifications, this peptide could be developed into a potent antimicrobial agent in the future. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2012.04.018 |